KALAMAZOO, Mich. The Upjohn Co. named a new president and chiefoperating officer and promoted another high-level executive after asetback in Chairman Theodore Cooper's fight with cancer.
Cooper, 64, was diagnosed in January with multiple myeloma, orcancer of the bone marrow. He was in critical but stable conditionThursday at the University of Virginia Medical Center with a lunginfection and respiratory failure, company officials said.
In a special meeting Wednesday, the board promoted Ley S. Smithfrom vice chairman to president and chief operating officer. WilliamU. Parfet, former president of the Kalamazoo-based pharmaceuticalmaker, was named a vice chairman.
"We are all very concerned for Dr. Cooper and his family anddisappointed in this setback in what appeared to be a good recovery,"said William Mulholland, senior outside member of the board'sexecutive committee.
Cooper returned to work in early March after spending six weeksin the hospital receiving radiation and chemotherapy.
On March 30, however, he returned to Virginia for acceleratedtreatment. Upjohn directors were notified Tuesday that Cooper hadbeen moved into the intensive-care unit.
Smith also will assume chief executive officer responsibilitiesin Cooper's absence.
Parfet will remain responsible for Upjohn's allied healthbusinesses, worldwide manufacturing and finance.
Комментариев нет:
Отправить комментарий